vs
Side-by-side financial comparison of ARGENX SE (ARGX) and Canadian Solar Inc. (CSIQ). Click either name above to swap in a different company.
Canadian Solar Inc. is the larger business by last-quarter revenue ($4.5B vs $2.5B, roughly 1.8× ARGENX SE). ARGENX SE runs the higher net margin — 35.5% vs 1.3%, a 34.2% gap on every dollar of revenue.
AbbVie Inc. is an American pharmaceutical company headquartered in North Chicago, Illinois. They have produced drugs to treat a wide range of medical issues.
Canadian Solar Inc. is a global renewable energy company. Headquartered in Kitchener, Ontario, the company manufactures solar PV modules, provides battery energy storage solutions and develops utility-scale solar power and battery energy storage projects.
ARGX vs CSIQ — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $2.5B | $4.5B |
| Net Profit | $877.2M | $57.6M |
| Gross Margin | 89.5% | 17.5% |
| Operating Margin | 28.9% | 2.2% |
| Net Margin | 35.5% | 1.3% |
| Revenue YoY | 83.2% | — |
| Net Profit YoY | 1.3% | — |
| EPS (diluted) | $13.25 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $2.5B | — | ||
| Q3 25 | — | $4.5B | ||
| Q2 25 | $1.8B | $3.0B | ||
| Q1 25 | — | $1.3B | ||
| Q4 24 | $1.4B | — | ||
| Q3 24 | — | $5.9B | ||
| Q2 24 | $901.9M | $4.1B | ||
| Q2 23 | $510.9M | — |
| Q4 25 | $877.2M | — | ||
| Q3 25 | — | $57.6M | ||
| Q2 25 | $414.8M | $63.6M | ||
| Q1 25 | — | $36.2M | ||
| Q4 24 | $865.6M | — | ||
| Q3 24 | — | $366.8M | ||
| Q2 24 | $-32.5M | $304.4M | ||
| Q2 23 | $-123.2M | — |
| Q4 25 | 89.5% | — | ||
| Q3 25 | — | 17.5% | ||
| Q2 25 | 89.2% | 18.0% | ||
| Q1 25 | — | 19.0% | ||
| Q4 24 | 90.2% | — | ||
| Q3 24 | — | 18.0% | ||
| Q2 24 | 89.4% | 18.7% | ||
| Q2 23 | 91.7% | — |
| Q4 25 | 28.9% | — | ||
| Q3 25 | — | 2.2% | ||
| Q2 25 | 19.2% | 3.3% | ||
| Q1 25 | — | 3.7% | ||
| Q4 24 | 8.7% | — | ||
| Q3 24 | — | 7.7% | ||
| Q2 24 | -15.4% | 9.1% | ||
| Q2 23 | -40.3% | — |
| Q4 25 | 35.5% | — | ||
| Q3 25 | — | 1.3% | ||
| Q2 25 | 23.4% | 2.1% | ||
| Q1 25 | — | 2.7% | ||
| Q4 24 | 64.1% | — | ||
| Q3 24 | — | 6.2% | ||
| Q2 24 | -3.6% | 7.5% | ||
| Q2 23 | -24.1% | — |
| Q4 25 | $13.25 | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $6.32 | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $13.33 | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $-0.55 | — | ||
| Q2 23 | $-2.21 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $3.5B | $1.7B |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $7.3B | $3.9B |
| Total Assets | $8.7B | $13.5B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $3.5B | — | ||
| Q3 25 | — | $1.7B | ||
| Q2 25 | $2.1B | $1.7B | ||
| Q1 25 | — | $1.7B | ||
| Q4 24 | $1.5B | — | ||
| Q3 24 | — | $1.9B | ||
| Q2 24 | $1.4B | $1.9B | ||
| Q2 23 | $1.1B | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $11.0M | — | ||
| Q2 23 | — | — |
| Q4 25 | $7.3B | — | ||
| Q3 25 | — | $3.9B | ||
| Q2 25 | $6.1B | $3.9B | ||
| Q1 25 | — | $3.9B | ||
| Q4 24 | $5.5B | — | ||
| Q3 24 | — | $3.7B | ||
| Q2 24 | $4.3B | $3.7B | ||
| Q2 23 | $2.9B | — |
| Q4 25 | $8.7B | — | ||
| Q3 25 | — | $13.5B | ||
| Q2 25 | $7.2B | $13.5B | ||
| Q1 25 | — | $13.5B | ||
| Q4 24 | $6.2B | — | ||
| Q3 24 | — | $11.9B | ||
| Q2 24 | $4.8B | $11.9B | ||
| Q2 23 | $3.2B | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 0.00× | — | ||
| Q2 23 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $323.3M | $-187.7M |
| Free Cash FlowOCF − Capex | $322.4M | — |
| FCF MarginFCF / Revenue | 13.0% | — |
| Capex IntensityCapex / Revenue | 0.0% | — |
| Cash ConversionOCF / Net Profit | 0.37× | -3.26× |
| TTM Free Cash FlowTrailing 4 quarters | $594.5M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $323.3M | — | ||
| Q3 25 | — | $-187.7M | ||
| Q2 25 | $361.8M | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $41.9M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $-124.7M | — | ||
| Q2 23 | $-285.4M | — |
| Q4 25 | $322.4M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $356.6M | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $40.9M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $-125.5M | — | ||
| Q2 23 | $-285.9M | — |
| Q4 25 | 13.0% | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 20.1% | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 3.0% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -13.9% | — | ||
| Q2 23 | -56.0% | — |
| Q4 25 | 0.0% | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.3% | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.1% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 0.1% | — | ||
| Q2 23 | 0.1% | — |
| Q4 25 | 0.37× | — | ||
| Q3 25 | — | -3.26× | ||
| Q2 25 | 0.87× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.05× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q2 23 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
